CEACAM3 and colorectal carcinoma: In spite of some limitations, the present study confirmed the specificity of CEACAM3 as marker of CCTs and showed, for the first time, a perioperative trend of CTCs which is coherent with what could be expected on the basis of clinical considerations and previous experimental findings which have been reported for both CRC and other neoplasms.